Software - Application
Compare Stocks
5 / 10Stock Comparison
AGYS vs REZI vs JCI vs PAR vs HON
Revenue, margins, valuation, and 5-year total return — side by side.
Security & Protection Services
Construction
Software - Application
Conglomerates
AGYS vs REZI vs JCI vs PAR vs HON — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Security & Protection Services | Construction | Software - Application | Conglomerates |
| Market Cap | $2.05B | $6.04B | $85.23B | $617M | $136.91B |
| Revenue (TTM) | $311M | $7.47B | $24.43B | $476M | $36.76B |
| Net Income (TTM) | $30M | $-527M | $3.53B | $-76M | $4.10B |
| Gross Margin | 60.9% | 29.4% | 36.6% | 40.1% | 36.9% |
| Operating Margin | 10.6% | 8.1% | 13.6% | -13.5% | 14.9% |
| Forward P/E | 44.3x | 13.1x | 29.4x | 28.3x | 20.5x |
| Total Debt | $47M | $3.17B | $11.19B | $402M | $34.58B |
| Cash & Equiv. | $73M | $661M | $379M | $80M | $12.49B |
AGYS vs REZI vs JCI vs PAR vs HON — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Agilysys, Inc. (AGYS) | 100 | 379.3 | +279.3% |
| Resideo Technologie… (REZI) | 100 | 570.4 | +470.4% |
| Johnson Controls In… (JCI) | 100 | 443.3 | +343.3% |
| PAR Technology Corp… (PAR) | 100 | 59.9 | -40.1% |
| Honeywell Internati… (HON) | 100 | 148.1 | +48.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AGYS vs REZI vs JCI vs PAR vs HON
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AGYS is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 5.7% 10Y total return vs JCI's 343.3%
- Lower volatility, beta 0.87, Low D/E 17.7%, current ratio 1.11x
REZI has the current edge in this matchup, primarily because of its strength in value and momentum.
- Lower P/E (13.1x vs 28.3x)
- +111.6% vs PAR's -75.6%
JCI is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 1.15 vs HON's 11.18
- 14.5% margin vs PAR's -16.0%
- 9.0% ROA vs REZI's -6.2%, ROIC 8.5% vs 9.0%
PAR is the clearest fit if your priority is growth exposure.
- Rev growth 30.2%, EPS growth -13.9%, 3Y rev CAGR 20.2%
- 30.2% revenue growth vs JCI's 2.8%
HON ranks third and is worth considering specifically for income & stability and defensive.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Beta 0.74, yield 2.1%, current ratio 1.32x
- Beta 0.74 vs REZI's 2.27
- 2.1% yield, 15-year raise streak, vs JCI's 1.1%, (2 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 30.2% revenue growth vs JCI's 2.8% | |
| Value | Lower P/E (13.1x vs 28.3x) | |
| Quality / Margins | 14.5% margin vs PAR's -16.0% | |
| Stability / Safety | Beta 0.74 vs REZI's 2.27 | |
| Dividends | 2.1% yield, 15-year raise streak, vs JCI's 1.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +111.6% vs PAR's -75.6% | |
| Efficiency (ROA) | 9.0% ROA vs REZI's -6.2%, ROIC 8.5% vs 9.0% |
AGYS vs REZI vs JCI vs PAR vs HON — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AGYS vs REZI vs JCI vs PAR vs HON — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AGYS leads in 2 of 6 categories
REZI leads 2 • HON leads 1 • JCI leads 0 • PAR leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AGYS leads this category, winning 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 118.3x AGYS's $311M. JCI is the more profitable business, keeping 14.5% of every revenue dollar as net income compared to PAR's -16.0%. On growth, PAR holds the edge at +19.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $311M | $7.5B | $24.4B | $476M | $36.8B |
| EBITDAEarnings before interest/tax | $43M | $802M | $3.9B | -$27M | $6.5B |
| Net IncomeAfter-tax profit | $30M | -$527M | $3.5B | -$76M | $4.1B |
| Free Cash FlowCash after capex | $59M | -$1.3B | $1.4B | -$29M | $4.2B |
| Gross MarginGross profit ÷ Revenue | +60.9% | +29.4% | +36.6% | +40.1% | +36.9% |
| Operating MarginEBIT ÷ Revenue | +10.6% | +8.1% | +13.6% | -13.5% | +14.9% |
| Net MarginNet income ÷ Revenue | +9.8% | -7.1% | +14.5% | -16.0% | +11.2% |
| FCF MarginFCF ÷ Revenue | +19.1% | -16.8% | +5.7% | -6.0% | +11.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.6% | +2.0% | +8.2% | +19.4% | -6.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +150.0% | +11.4% | +38.9% | +36.1% | -41.9% |
Valuation Metrics
REZI leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 29.4x trailing earnings, HON trades at a 67% valuation discount to AGYS's 88.9x P/E. Adjusting for growth (PEG ratio), JCI offers better value at 2.06x vs HON's 15.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.0B | $6.0B | $85.2B | $617M | $136.9B |
| Enterprise ValueMkt cap + debt − cash | $2.0B | $8.5B | $96.0B | $940M | $159.0B |
| Trailing P/EPrice ÷ TTM EPS | 88.94x | -10.68x | 52.95x | -7.16x | 29.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 44.33x | 13.07x | 29.38x | 28.32x | 20.52x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.06x | — | 15.99x |
| EV / EBITDAEnterprise value multiple | 66.14x | 10.65x | 26.01x | — | 19.99x |
| Price / SalesMarket cap ÷ Revenue | 7.43x | 0.81x | 3.61x | 1.36x | 3.66x |
| Price / BookPrice ÷ Book value/share | 7.75x | 2.06x | 7.03x | 0.73x | 9.00x |
| Price / FCFMarket cap ÷ FCF | 39.15x | — | 88.32x | — | 25.39x |
Profitability & Efficiency
AGYS leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JCI delivers a 24.9% return on equity — every $100 of shareholder capital generates $25 in annual profit, vs $-18 for REZI. AGYS carries lower financial leverage with a 0.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), JCI scores 6/9 vs PAR's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.7% | -18.1% | +24.9% | -9.1% | +23.1% |
| ROA (TTM)Return on assets | +6.4% | -6.2% | +9.0% | -5.5% | +5.3% |
| ROICReturn on invested capital | +9.5% | +9.0% | +8.5% | -4.2% | +12.6% |
| ROCEReturn on capital employed | +7.7% | +9.3% | +9.8% | -5.1% | +12.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 6 | 2 | 6 |
| Debt / EquityFinancial leverage | 0.18x | 1.09x | 0.86x | 0.49x | 2.24x |
| Net DebtTotal debt minus cash | -$26M | $2.5B | $10.8B | $323M | $22.1B |
| Cash & Equiv.Liquid assets | $73M | $661M | $379M | $80M | $12.5B |
| Total DebtShort + long-term debt | $47M | $3.2B | $11.2B | $402M | $34.6B |
| Interest CoverageEBIT ÷ Interest expense | 55.21x | -2.36x | 18.41x | -21.71x | 3.92x |
Total Returns (Dividends Reinvested)
REZI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JCI five years ago would be worth $22,286 today (with dividends reinvested), compared to $1,914 for PAR. Over the past 12 months, REZI leads with a +111.6% total return vs PAR's -75.6%. The 3-year compound annual growth rate (CAGR) favors REZI at 34.9% vs PAR's -20.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -36.9% | +14.5% | +14.2% | -58.1% | +10.9% |
| 1-Year ReturnPast 12 months | -7.0% | +111.6% | +56.9% | -75.6% | +2.8% |
| 3-Year ReturnCumulative with dividends | -4.2% | +145.5% | +127.9% | -49.2% | +16.2% |
| 5-Year ReturnCumulative with dividends | +39.8% | +33.0% | +122.9% | -80.9% | +3.3% |
| 10-Year ReturnCumulative with dividends | +571.5% | +38.9% | +343.3% | +167.3% | +135.1% |
| CAGR (3Y)Annualised 3-year return | -1.4% | +34.9% | +31.6% | -20.2% | +5.1% |
Risk & Volatility
Evenly matched — JCI and HON each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than REZI's 2.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JCI currently trades 94.5% from its 52-week high vs PAR's 20.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.87x | 2.27x | 0.97x | 1.54x | 0.74x |
| 52-Week HighHighest price in past year | $145.25 | $45.29 | $147.32 | $72.15 | $248.18 |
| 52-Week LowLowest price in past year | $61.50 | $18.88 | $87.77 | $11.59 | $186.76 |
| % of 52W HighCurrent price vs 52-week peak | +50.2% | +88.9% | +94.5% | +20.7% | +87.1% |
| RSI (14)Momentum oscillator 0–100 | 50.7 | 61.4 | 56.2 | 47.3 | 45.1 |
| Avg Volume (50D)Average daily shares traded | 277K | 1.1M | 3.3M | 1.9M | 3.7M |
Analyst Outlook
HON leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AGYS as "Buy", REZI as "Buy", JCI as "Buy", PAR as "Buy", HON as "Buy". Consensus price targets imply 67.0% upside for PAR (target: $25) vs -0.9% for JCI (target: $138). For income investors, HON offers the higher dividend yield at 2.14% vs REZI's 0.58%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $105.00 | $40.00 | $138.00 | $25.00 | $243.83 |
| # AnalystsCovering analysts | 8 | 7 | 45 | 11 | 28 |
| Dividend YieldAnnual dividend ÷ price | — | +0.6% | +1.1% | — | +2.1% |
| Dividend StreakConsecutive years of raises | 0 | 2 | 5 | 1 | 15 |
| Dividend / ShareAnnual DPS | — | $0.23 | $1.49 | — | $4.63 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | +7.0% | +1.1% | +2.8% |
AGYS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). REZI leads in 2 (Valuation Metrics, Total Returns). 1 tied.
AGYS vs REZI vs JCI vs PAR vs HON: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AGYS or REZI or JCI or PAR or HON a better buy right now?
For growth investors, PAR Technology Corporation (PAR) is the stronger pick with 30.
2% revenue growth year-over-year, versus 2. 8% for Johnson Controls International plc (JCI). Honeywell International Inc. (HON) offers the better valuation at 29. 4x trailing P/E (20. 5x forward), making it the more compelling value choice. Analysts rate Agilysys, Inc. (AGYS) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AGYS or REZI or JCI or PAR or HON?
On trailing P/E, Honeywell International Inc.
(HON) is the cheapest at 29. 4x versus Agilysys, Inc. at 88. 9x. On forward P/E, Resideo Technologies, Inc. is actually cheaper at 13. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Johnson Controls International plc wins at 1. 15x versus Honeywell International Inc. 's 11. 18x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — AGYS or REZI or JCI or PAR or HON?
Over the past 5 years, Johnson Controls International plc (JCI) delivered a total return of +122.
9%, compared to -80. 9% for PAR Technology Corporation (PAR). Over 10 years, the gap is even starker: AGYS returned +571. 5% versus REZI's +38. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AGYS or REZI or JCI or PAR or HON?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Resideo Technologies, Inc. 's 2. 27β — meaning REZI is approximately 207% more volatile than HON relative to the S&P 500. On balance sheet safety, Agilysys, Inc. (AGYS) carries a lower debt/equity ratio of 18% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AGYS or REZI or JCI or PAR or HON?
By revenue growth (latest reported year), PAR Technology Corporation (PAR) is pulling ahead at 30.
2% versus 2. 8% for Johnson Controls International plc (JCI). On earnings-per-share growth, the picture is similar: Johnson Controls International plc grew EPS 4. 4% year-over-year, compared to -1392. 9% for PAR Technology Corporation. Over a 3-year CAGR, PAR leads at 20. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AGYS or REZI or JCI or PAR or HON?
Johnson Controls International plc (JCI) is the more profitable company, earning 13.
9% net margin versus -18. 5% for PAR Technology Corporation — meaning it keeps 13. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HON leads at 17. 5% versus -14. 0% for PAR. At the gross margin level — before operating expenses — AGYS leads at 62. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AGYS or REZI or JCI or PAR or HON more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Johnson Controls International plc (JCI) is the more undervalued stock at a PEG of 1. 15x versus Honeywell International Inc. 's 11. 18x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Resideo Technologies, Inc. (REZI) trades at 13. 1x forward P/E versus 44. 3x for Agilysys, Inc. — 31. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PAR: 67. 0% to $25. 00.
08Which pays a better dividend — AGYS or REZI or JCI or PAR or HON?
In this comparison, HON (2.
1% yield), JCI (1. 1% yield), REZI (0. 6% yield) pay a dividend. AGYS, PAR do not pay a meaningful dividend and should not be held primarily for income.
09Is AGYS or REZI or JCI or PAR or HON better for a retirement portfolio?
For long-horizon retirement investors, Honeywell International Inc.
(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 1% yield, +135. 1% 10Y return). PAR Technology Corporation (PAR) carries a higher beta of 1. 54 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HON: +135. 1%, PAR: +167. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AGYS and REZI and JCI and PAR and HON?
These companies operate in different sectors (AGYS (Technology) and REZI (Industrials) and JCI (Industrials) and PAR (Technology) and HON (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AGYS is a small-cap high-growth stock; REZI is a small-cap quality compounder stock; JCI is a mid-cap quality compounder stock; PAR is a small-cap high-growth stock; HON is a mid-cap quality compounder stock. REZI, JCI, HON pay a dividend while AGYS, PAR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.